This inventor holds 1 USPTO granted patent. Top assignee: Nihon Tenganyaku Kenkyusho Co., Ltd.. Active years: 2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012
Title: Hiroaki Iwata: Innovator in Ophthalmological Composition
Introduction
Hiroaki Iwata is a notable inventor based in Kusagai, Japan. He has made significant contributions to the field of ophthalmology through his innovative research and development. His work focuses on creating effective treatments for corneal disorders.
Latest Patents
Hiroaki Iwata holds a patent for an ophthalmological composition. The patent aims to identify the minimum activity expression site of fibronectin and clarify its actions in relation to ophthalmological fields. This invention provides a corneal disorder treatment agent that contains the peptide PHSRN (SEQ ID NO: 1) or its derivatives. The preferred dosage form for this composition is an ophthalmic formulation.
Career Highlights
Iwata is associated with Nihon Tenganyaku Kenkyusho Co., Ltd., where he continues to advance his research in ophthalmology. His dedication to improving medical treatments has positioned him as a key figure in his field.
Collaborations
Hiroaki Iwata has collaborated with notable colleagues, including Teruo Nishida and Yorihisa Uetake. These partnerships have contributed to the success of his research and the development of innovative solutions in ophthalmology.
Conclusion
Hiroaki Iwata's contributions to ophthalmological compositions demonstrate his commitment to advancing medical science. His innovative work continues to impact the treatment of corneal disorders, showcasing the importance of research and collaboration in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile